SOURCE-LINKED INTELLIGENCE

Archibiome tattoo for resistant, responsive, and resilient cities

CORDIS · observation · Publication date unknown

reated microbial consortia along every step in the development of living inks. In silico analysis will be applied to predict combinations of microorganisms based on genome-scale models of metabolism. Machine learning models will be implemented for predictive analysis of growth patterns and structural outcomes, providing insights for further optimising ink formulations and printing parameters. REMEDY will introduce metabolic thinking in the circular building industry, boost probiotic architecture, and initiate a microbial revolution that aims to change the negative perception of microorganisms in architecture. The “high-risk” idea proposed by the interdisciplinary consortium will deliver a “high-gain” solution in the form of probiotic architecture. REMEDY will provide a new dimension that has not yet existed for conventional materials – life. It will change the way we perceive, experience, understand, design, use, and transform materials. living ink, engineered living materials, biofabrication, microbiome

Read original source ↗ Open in workspace

recordType

award

status

SIGNED

region

EU

value

2998122.5

unit

EUR